Global Electromagnetic Therapy Devices Market by Product Type (High Frequency, Low Frequency), By Application (Bone Growth, Pain Relief), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2030 (Includes Business Impact of COVID-19)

                                          
Report updated on 11th September, 2021: Global Electromagnetic Therapy Devices Market by Product Type (High Frequency, Low Frequency), By Application (Bone Growth, Pain Relief), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2030 (Includes Business Impact of COVID-19)
Trusted Business Insights has published a comprehensive market research report on, Global Electromagnetic Therapy Devices Market by Product Type (High Frequency, Low Frequency), By Application(Bone Growth, Pain Relief), and by Region -Global Forecast to 2030, which offers a holistic view of the global electromagnetic therapy devices market through systematic segmentation that covers every aspect of the target market.

The global electromagnetic therapy devices market is projected to be US$ 350.7 Mn in 2020 to reach US$ 685.6 Mn by 2030 at a CAGR of 6.9%.

Electromagnetic devices are the medical devices which uses electromagnetic pulses in the electromagnetic therapy. Electromagnetic therapy is a somehow pseudoscientific form of alternative medicine which claims to treat disease by applying electromagnetic radiation to the body. Magnetic energy exists in our body and it controls the heartbeats, it stimulates muscles, and more. Each molecule in the human body contains a small amount of magnetic energy. Electromagnetic Therapy Devices are commonly used in Bone Growth, Pain Relief and other field. The assumption is that, imbalance due to electromagnetic frequencies causing illness in the body can be corrected by electromagnetic therapy. Electromagnetic therapy is also known as bioelectricity, magneto biology, magnetic field therapy, and magnetic healing. Applications like instant pain relief, bone growth etc. are expected to grow this market. Use of Devices are supplementary with surgery this could anticipate to drive the market. US food and drug Administration (FDA) has approved some instruments this could help to boost the market.

Due to time limitation people prefer to use quick relief devices like electromagnetic therapy devices to get rid of pain and due to ever-increasing geriatric population worldwide, market of electromagnetic devices is expected to grow at high. PEMF therapy devices for particular ailments like healing of nonunion fractures, urinary incontinence and muscle stimulation are approved by FDA this could help market to grow. Technology enhancement in the healthcare sector of some emerging nations is expected to fuel the growth of electromagnetic devices market.


Global Electromagnetic Therapy Devices Market Revenue (US$ Mn), 2021 to 2030


Government has some rules and regulations on the usage of this devices with respect of electromagnetic waves and some side effects from these devices like pain, nausea, dizziness etc. can decrease the market growth.


Global Electromagnetic Therapy Devices Market by Formulation, 2018


Low frequency devices accounts majority share in global electromagnetic therapy device market.
On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, MEA. The North America accounts for the majority share in the global electromagnetic therapy device market, followed by Europe.

The research report on the global electromagnetic therapy device market includes profiles of some of major companies such as Orthofix Medical Inc., Swiss Bionic Solutions, Curatronic Ltd., Dolphin Neurostim, BEMER AG, Oxford Medical Instruments Ltd, Medithera GmbH, EarthPulse, Orin Group, I Tech Medical Division etc.



Below are the active patents related to Electromagnetic Therapy Devices Market.


Patent Number: US20110004261A1

Electromagnetic thermal therapy

Abstract

A portable, non-invasive device for providing therapeutic treatment to a joint to promote healing of the joint includes a cuff positionable around the joint. The cuff includes an electromagnetic stimulator configured to provide an electromagnetic field within the joint and a single-use thermal exchange component configured to provide temperature-based therapy to the joint.

Application File Date: 2010-07-07

Application Granted Date: 2014-07-01

Current Assignee: OrthoCor Medical Inc

Patent Number: US8489206B2

Device for neuronal therapies

Abstract

A device for neuronal therapies comprising a high frequency and/or very high frequency generator (1) functioning by means of coils (11), and associated with two main electrodes (2), which are respectively configured by a core (21) of insulating material with the front end (22) in point form and surrounded by a flexible insulating tubular body (23) extended on the point end (22) of the electrode for separate and safe positioning thereof with respect to the eyes of the patient on which said electrodes (2) are placed in a use operation, in order to cause stimulation of the nervous system and improvement of neuronal transmission by means of the circulation of high frequency currents. Both electrodes (2) are associated with at least one element for support (3) and positioning over the eyes of the patient, based on an element for fastening (4) to the head or a cabi

Application File Date: 2007-07-16

Application Granted Date: 2013-07-16

Current Assignee: Novasonix Technology Sl

Key Market Segments

By Type:

  
High Frequency
  
Low Frequency

By Application:

  
Bone Growth
  
Pain Relief
  
Others


Key Market Players included in the report:


  
Banglijian
  
BEMER AG
  
Curatronic Ltd.
  
Dolphin Neurostim
  
EarthPulse
  
Green Sea
  
HealthyLine
  
I Tech Medical Division
  
Medithera GmbH
  
NiuDeSai
  
OMI
  
Orin Group
  
Orthofix Medical Inc.
  
Oxford Medical Instruments Ltd
  
Swiss Bionic Solutions


 Below are the key development related to Electromagnetic Therapy Devices Market in 2020 and 2021.


April 2021: Orthofix signs exclusive licensing agreement for Igea’s bone and joint stimulation devices. Orthofix (NSDQ:OFIX) said it entered an exclusive license agreement to commercialize Igea‘s bone, cartilage and soft tissue stimulation products in the U.S. and Canada. Through the agreement, Orthofix has the rights to pursue FDA approvals and commercialization of Italy-based Igea’s platform of orthopedic products. Orthofix will market the products, which will expand its bone growth therapies portfolio of pulsed electromagnetic field (PEMF) products with other indications for low-intensity pulsed ultrasound (LIPUS) and capacitive coupling (CC) for fracture management. Source

Dec 2020: NuLife Ventures Introduces PEMF Therapy Device, Sedona Face. The benefits of PEMF (Pulsed Electro-Magnetic Field) therapy is no secret among wellness experts with a four-year study conducted by NASA to understand its benefits and effects on human wellbeing. NuLife Ventures introduces a portable and affordable PEMF therapy device called the
Sedona Face uses advanced modern technology to treat the face with PEMF therapy. The devices possible anti-aging benefits may come from increased blood circulation and increased saturation of oxygen and other nutrients helping damaged cells become rejuvenated. Increased oxygen can also help create new healthy cells. Source

September 2020: Intersect ENT Announces Agreement to Acquire Fiagon AG Medical Technologies for €60 million Paid Over Three Years. Intersect ENT, Inc. (Nasdaq: XENT), a company transforming care for patients with ear, nose and throat (“ENT”) conditions, announced it has entered into an agreement to acquire Fiagon AG Medical Technologies, a leader in electromagnetic surgical navigation solutions, for €60 million in cash. Under the terms of the transaction, Intersect ENT will make an initial €15 million payment at the time of the closing and €15 million annual payments for the subsequent three years. The acquisition is expected to close within 30 days, subject to customary closing conditions. Source